Partners

Helsingborg Hospital, a part of the Region Skane SUND is the main trial sponsor. 

Lund University is the main academic institution affiliated to the TTM2-trial

Main funding organisation. The TTM-2 trial is supported by a clinical research environment grant. Grant Nr: 2016-00428

The Swedish Research Council is a public agency under the authority of the Ministry of Education and Research. The Swedish Research Council has a leading role in developing Swedish research of the highest scientific quality, thereby contributing to the development of society.

The TTM2 trial is funded by The Swedish Heart-Lung Foundation

The TTM2-trial is supported by an independent research grant from The Gorthon foundation, which supports medical research and training in Helsingborg, Sweden. 

The TTM2 Trial is supported by an independent research grant from the Knutsson Foundation

The TTM2-trial is supported by an independent research grant from the Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research

Collaborating RCT. Investigating the effect of mild hypercapnia following out-of-hospital cardiac arrest.

ANZ Clinical Trials Registry Number: ACTRN12617000036314p

Clinicaltrials.gov: NCT03114033

Trial methodology development

Trial monitoring.
Clinical Studies Sweden is a collaboration between the Swedish Research Council and Sweden's Health Care regions. In addition to the six regional nodes, the system consists of the Committee for Clinical Studies and the Office for Clinical Studies at the Swedish Research Council.